Partners
AstraZeneca is a major international healthcare business engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines.
We believe that we share one fundamental principle with the NHS: we both put patients at the heart of what we do. Our shared belief in putting patients first is a simple principle that should inspire us to develop true and meaningful partnerships that improve the health and quality of patients’ lives.
As a family owned company we are able to take a long term view. We understand that relationships take time to build with trust and reliability being an important foundation to any working relationship.
Recent evidence of our commitment to partnership can be seen through our proactive work with the NHS, patient and professional organisations, aimed at raising awareness and providing education about chronic obstructive pulmonary disease (COPD).
We can help develop bespoke solutions for NHS organisations to meet local and national priorities. We also have a skilled and experienced in-house team that can help develop value-added services to improve patient care. We are a natural fit for the NHS and ideal partners for people who are passionate about improving COPD patients' lives.
If you would like to know more about how we can help you to deliver world-class patient care, then please contact us. We look forward to exploring opportunities to work with you.
The British Lung Foundation is the only UK charity working for everyone affected by lung disease. We focus our resources on providing support for people affected by lung disease today; and work in a variety of ways, including funding world-class research, to bring about positive change, to improve treatment, care and support for people affected by lung disease now and in the future.
The BLF works in partnership with PCTs to deliver lung health awareness days offering lung function testing, smoking cessation advice and information on keeping lungs healthy. Our self management plans and exercise diaries for those diagnosed with COPD have just been updated in collaboration with healthcare professionals and the SHA Respiratory Leads. Both are designed to be used by the patient with the guidance of their healthcare professional. In addition to this we also offer a BLF Helpline, Breathe Easy Groups, PenPals and online forum, free information leaflets, BLF Nurses and BLF Active.
For more information please visit our stand at the event or contact the BLF Services Team on info@blfservices.co.uk or 020 7688 6026 www.lunguk.org
GlaxoSmithKline (GSK) is one of the world’s leading research based pharmaceutical and healthcare companies. We are committed to improving the quality of human life by enabling people to do more, feel better and live longer. We have a strong heritage in discovering and developing respiratory products and are committed to advancing the understanding and treatment of respiratory disease. We strive to be at the forefront of innovation in this field, providing products and support to help healthcare professionals and the NHS to improve the lives of people with COPD and asthma.
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products.
The Respiratory Research Centre at Horsham in West Sussex is the Novartis worldwide headquarters for respiratory research, employing over 300 scientists with the site also being the global centre for gastro-intestinal research for Novartis.
Novartis UK employs over 3,500 people across 9 sites. In the UK, the Novartis sites are involved in development, manufacturing, packaging, customer service and marketing for products used in the UK and worldwide.
For more information, please visit http://www.novartis.co.uk
Pfizer is delighted to be associated with this COPD meeting series and as one of the therapy areas supported by Pfizer’s medicines or research efforts we are committed to help the NHS achieve better quality services and increase productivity and efficiency. Our workshop will focus on how through its service offering we can support local health economies meet the challenges posed in implementing the COPD strategy.
Quintiles has evolved since its beginnings in 1982 as a clinical research organisation.
Today it is a fully integrated biopharmaceutical services company working directly with payers, such as the NHS, and biopharma and offers clinical, commercial, consulting and capital solutions.
Each of our business pillars informs the others. Knowledge culled from decades of on-the ground experience in the UK in clinical and commercial services informs our consulting and capital solutions. Strategic thinking and new alliance models drive innovative engagements that result in real deliverables.
By leveraging the breadth and depth of our expertise and services, biopharma and payers find greater efficiencies and better ways to offset risks to embrace opportunity. Quintiles can help you to establish effective screening and assessment programmes as well as programmes to help patients manage their disease better. All with the common objective in mind to ensure positive health outcomes for patients and help people living healthier, more fulfilling lives in the UK and all over the world.
For more information please contact us at newhealth@quntiles.com
GlaxoSmithKline (GSK) is one of the world’s leading research based pharmaceutical and healthcare companies. We are committed to improving the quality of human life by enabling people to do more, feel better and live longer. We have a strong heritage in discovering and developing respiratory products and are committed to advancing the understanding and treatment of respiratory disease. We strive to be at the forefront of innovation in this field, providing products and support to help healthcare professionals and the NHS to improve the lives of people with COPD and asthma.
Novartis provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products.
The Respiratory Research Centre at Horsham in West Sussex is the Novartis worldwide headquarters for respiratory research, employing over 300 scientists with the site also being the global centre for gastro-intestinal research for Novartis.
Novartis UK employs over 3,500 people across 9 sites. In the UK, the Novartis sites are involved in development, manufacturing, packaging, customer service and marketing for products used in the UK and worldwide. For more information, please visit http://www.novartis.co.uk
Pfizer is delighted to be associated with this COPD meeting series and as one of the therapy areas supported by Pfizer’s medicines or research efforts we are committed to help the NHS achieve better quality services and increase productivity and efficiency. Our workshop will focus on how through its service offering we can support local health economies meet the challenges posed in implementing the COPD strategy.
Quintiles has evolved since its beginnings in 1982 as a clinical research organisation.
Today it is a fully integrated biopharmaceutical services company working directly with payers, such as the NHS, and biopharma and offers clinical, commercial, consulting and capital solutions.
Each of our business pillars informs the others. Knowledge culled from decades of on-the ground experience in the UK in clinical and commercial services informs our consulting and capital solutions. Strategic thinking and new alliance models drive innovative engagements that result in real deliverables.
By leveraging the breadth and depth of our expertise and services, biopharma and payers find greater efficiencies and better ways to offset risks to embrace opportunity. Quintiles can help you to establish effective screening and assessment programmes as well as programmes to help patients manage their disease better. All with the common objective in mind to ensure positive health outcomes for patients and help people living healthier, more fulfilling lives in the UK and all over the world.
For more information please contact us at newhealth@quntiles.com